J Korean Neurosurg Soc.  1990 Dec;19(10-12):1422-1425.

Albendazole Therapy for Multiple Neurocysticercosis

Affiliations
  • 1Department of Neurology, Nonsan Baekjae Hospital, Nonsan, Korea.
  • 2Department of Neurosurgery, Nonsan Baekjae Hospital, Nonsan, Korea.

Abstract

Albendazole is a new drug for the treatment of cerebral cysticercosis. We have recently experience a case that had shown poor therapeutic response to praziquantel. The patient have multiple parenchymal cysts. She was treated with 15mg/kg/day of albendazole for 1 month to confirm healing of the intracranial lesion by the follow up brain CT scan and CSF-ELISA associated with marked clinical improvement.

Keyword

Albendazole; Neurocysticercosis; Chemotherapy

MeSH Terms

Albendazole*
Brain
Cysticercosis
Drug Therapy
Follow-Up Studies
Humans
Neurocysticercosis*
Praziquantel
Tomography, X-Ray Computed
Albendazole
Praziquantel
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr